Company
Tyra Biosciences, Inc. (TYRA)
Standardized SEC financial data for Tyra Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001863127 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-46.3%
Free cash flow
-$95.3M
Current ratio
14.67×
EPS (diluted)
$-2.01
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $7.2M | $20.6M | $43.0M | $62.5M | $80.1M | $102.9M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.5M | $302.4M | $252.2M | $59.0M | $93.0M | $78.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.8M | -$23.7M | -$50.3M | -$50.1M | -$69.8M | -$95.1M |
| Capital expenditures |
Get TYRA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TYRA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TYRA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"